MapLight Therapeutics (MPLT) director receives RSU and stock option grants

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. reported that director Nanna Liebach Luneborg received new equity awards as part of non-employee director compensation. She was granted 3,932 restricted stock units, each representing one share of voting common stock, and a stock option for 14,902 shares at an exercise price of $28.64 per share.

Both the RSUs and the option were granted under the company’s 2025 Equity Incentive Plan and will vest on the earlier of June 23, 2027, or the date of the next annual stockholder meeting, subject to her continuous service.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Luneborg Nanna Liebach

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	14,902	$0.00	--
Grant/Award	Voting Common Stock	3,932	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 14,902 shares (Direct, null); Voting Common Stock — 3,932 shares (Direct, null)

Footnotes (1)

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Key Figures

RSUs granted: 3,932 units Stock options granted: 14,902 shares Option exercise price: $28.64 per share +5 more

8 metrics

RSUs granted 3,932 units Restricted stock units awarded to director on June 23, 2026

Stock options granted 14,902 shares Option for voting common stock granted to director

Option exercise price $28.64 per share Exercise price for director’s stock option grant

Option expiration June 22, 2036 Expiration date of director’s stock option grant

RSU vesting date June 23, 2027 (or earlier meeting) Vests on earlier of June 23, 2027 or next annual meeting

Option vesting date June 23, 2027 (or earlier meeting) Option vests on earlier of June 23, 2027 or next annual meeting

Shares after RSU grant 3,932 shares Total voting common stock following RSU transaction

Options after grant 14,902 options Total derivative position following option grant

Key Terms

restricted stock units ("RSUs"), 2025 Equity Incentive Plan, Continuous Service, non-employee director compensation policy, +1 more

5 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2025 Equity Incentive Plan financial

"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan")"

Continuous Service financial

"subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date"

non-employee director compensation policy financial

"This grant was made pursuant to the Issuer's non-employee director compensation policy"

stock option financial

"Represents a stock option granted pursuant to the Plan"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 05:57 PM Accepted by SEC EDGAR 06/25/2026 - 05:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Luneborg Nanna Liebach

(Last) (First) (Middle)

C/O MAPLIGHT THERAPEUTICS, INC.

800 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MapLight Therapeutics, Inc. [ MPLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Voting Common Stock	06/23/2026		A		3,932(1)	A	$0(2)	3,932	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$28.64	06/23/2026		A		14,902		(3)	06/22/2036	Voting Common Stock	14,902	$0	14,902	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

3. Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

	/s/ Kristopher L. Hanson, Attorney-in-Fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MapLight Therapeutics (MPLT) report for Nanna Liebach Luneborg?

MapLight reported that director Nanna Liebach Luneborg received equity awards as compensation. She was granted 3,932 restricted stock units and a stock option for 14,902 shares, providing future rights to voting common stock if vesting and exercise conditions are met.

How many RSUs were granted to the MapLight (MPLT) director and what do they represent?

The director received 3,932 restricted stock units. Each RSU represents a contingent right to receive one share of MapLight’s voting common stock, delivering actual shares only when the vesting conditions and continuous service requirements under the 2025 Equity Incentive Plan are satisfied.

What are the key terms of the stock option granted to the MapLight (MPLT) director?

The director was granted a stock option covering 14,902 shares of voting common stock at an exercise price of $28.64 per share. The option expires on June 22, 2036, and vests based on continued board service through the specified vesting date.

When do the MapLight (MPLT) director’s RSUs and stock options vest?

Both the RSUs and the stock option vest on the earlier of June 23, 2027, or the date of MapLight’s next annual stockholder meeting. Vesting is conditioned on the director maintaining Continuous Service, as defined in the company’s 2025 Equity Incentive Plan.

Under which plan were the MapLight (MPLT) director’s equity awards granted?

The RSUs and stock option were granted under MapLight’s 2025 Equity Incentive Plan. The filing states that these awards were made pursuant to the company’s non-employee director compensation policy, aligning director pay with equity interests in the business.

Are the MapLight (MPLT) director’s equity awards part of a purchase or compensation grant?

The awards are compensation grants, not open-market purchases. The Form 4 labels both transactions with code A for grant or award, and the footnotes explain they were issued under the 2025 Equity Incentive Plan and non-employee director compensation policy, rather than being bought for cash.